Volume 16, Number 1—January 2010
Dispatch
Acute Encephalopathy Associated with Influenza A Infection in Adults
Table 1
Clinical and laboratory findings | Patient 1 | Patient 2 | Patient 3 |
---|---|---|---|
Age, y/sex | 76/M | 86/F | 72/M |
Concurrent illnesses | Ischemic heart disease | Diabetes mellitus, hypertension | COPD |
Influenza vaccination within 6 mo | None | None | None |
Symptoms on examination |
Fever >38°C, cough, disorientation, incoherent speech, mental dullness |
Fever >38°C, cough, delirious, impaired consciousness, did not follow verbal command |
Fever >38°C, cough, disorientation, agitation, incoherent speech, involuntary 4-limb tremor |
Focal neurologic sign or meningism | Absent | Absent | Absent |
Chest radiograph, consolidation | Absent | Absent | Absent |
Antiviral (oseltamvir) | None | Given | Given |
Outcome (duration of encephalopathy) | Recovered (2–3 d) | Recovered (3–4 d) | Recovered (6–7 d) |
Brain CT scan (noncontrast) | Normal | Old ischemic changes; known small, calcified meningioma | Normal |
Virus isolated from NPA |
Seasonal (H1N1) 2008 |
Subtype H3N2 |
Subtype H3N2 |
CSF testing results | |||
Opening pressure, cm H2O | 11 | 9 | 14 |
Cell count (x 106/L) | 1 | – | 0 |
Glucose, mmol/L | 4.2 | 7.4 | 3.7 |
Protein, g/L | 0.46 | 0.47 | 0.16 |
Virus isolated | None | None | None |
RT-PCR for H3 and H1 influenza virus | Negative | Negative | Negative |
Bacterial culture | Negative | Negative | Negative |
Others | HSV, HZV, and enterovirus PCR negative | HSV, HZV, and enterovirus PCR negative | HSV PCR negative |
*COPD, chronic obstructive pulmonary disease; CT, computed tomographic scan; NPA, nasopharyngeal aspirate; CSF, cerebrospinal fluid; RT-PCR, reverse transcription–PCR; HSV, herpes simples virus; HZV, herpes zoster virus. In all cases, there was no hypoglycemia, and liver and renal function test results were normal. C-reactive protein level was elevated in all cases. For patient 3, an electroencephalogram was performed and showed generalized slowing of background consistent with moderate encephalopathic change (similar to that observed in septic encephalopathy) (1,6). Findings are consistent with previous reports on adult cases of influenza-associated encephalopathy: patients are all unvaccinated, pleocytosis and cerebral imaging abnormalities (even with magnetic resonance imaging) are usually absent, and symptoms are generally self-limiting (1,6). Most reports have mentioned influenza A as a cause of encephalopathy, and more commonly subtype H3N2 (1–6).
References
- Studahl M. Influenza virus and CNS manifestations. J Clin Virol. 2003;28:225–32. DOIPubMedGoogle Scholar
- Morishima T, Togashi T, Yokota S, Okuno Y, Miyazaki C, Tashiro M, ; Collaborative Study Group on Influenza-Associated Encephalopathy in Japan. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis. 2002;35:512–7. DOIPubMedGoogle Scholar
- Togashi T, Matsuzono Y, Narita M, Morishima T. Influenza-associated acute encephalopathy in Japanese children in 1994–2002. Virus Res. 2004;103:75–8. DOIPubMedGoogle Scholar
- Kawada J, Kimura H, Ito Y, Hara S, Iriyama M, Yoshikawa T, Systemic cytokine responses in patients with influenza-associated encephalopathy. J Infect Dis. 2003;188:690–8. DOIPubMedGoogle Scholar
- van Zeijl JH, Bakkers J, Wilbrink B, Melchers WJ, Mullaart RA, Galama JM. Influenza-associated encephalopathy: no evidence for neuroinvasion by influenza virus nor for reactivation of human herpesvirus 6 or 7. Clin Infect Dis. 2005;40:483–5. DOIPubMedGoogle Scholar
- Steininger C, Popow-Kraupp T, Laferl H, Seiser A, Gödl I, Djamshidian S, Acute encephalopathy associated with influenza A virus infection. Clin Infect Dis. 2003;36:567–74. DOIPubMedGoogle Scholar
- Lee N, Wong CK, Chan PKS, Lun SWM, Lui G, Wong B, Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A infections. Clin Infect Dis. 2007;45:723–31. DOIPubMedGoogle Scholar
- Ichiyama T, Morishima T, Isumi H, Matsufuji H, Matsubara T, Furukawa S. Analysis of cytokine levels and NF-kappaB activation in peripheral blood mononuclear cells in influenza virus-associated encephalopathy. Cytokine. 2004;27:31–7. DOIPubMedGoogle Scholar
- Lahrtz F, Piali L, Spanaus KS, Seebach J, Fontana A. Chemokines and chemotaxis of leukocytes in infectious meningitis. J Neuroimmunol. 1998;85:33–43. DOIPubMedGoogle Scholar
- Sprenger H, Rösler A, Tonn P, Braune HJ, Huffmann G, Gemsa D. Chemokines in the cerebrospinal fluid of patients with meningitis. Clin Immunol Immunopathol. 1996;80:155–61. DOIPubMedGoogle Scholar
- Lindegårdh N, Hanpithakpong W, Wattanagoon Y, Singhasivanon P, White NJ, Day NP. Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;859:74–83. DOIPubMedGoogle Scholar
- Semmler A, Hermann S, Mormann F, Weberpals M, Paxian SA, Okulla T, Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J Neuroinflammation. 2008;5:38. DOIPubMedGoogle Scholar
- Wang G, Zhang J, Li W, Xin G, Su Y, Gao Y, Apoptosis and proinflammatory cytokine responses of primary mouse microglia and astrocytes induced by human H1N1 and avian H5N1 influenza viruses. Cell Mol Immunol. 2008;5:113–20. DOIPubMedGoogle Scholar
- Yokota S, Imagawa T, Miyamae T, Ito S, Nakajima S, Nezu A, Hypothetical pathophysiology of acute encephalopathy and encephalitis related to influenza virus infection and hypothermia therapy. Pediatr Int. 2000;42:197–203. DOIPubMedGoogle Scholar
- Jhee SS, Yen M, Ereshefsky L, Leibowitz M, Schulte M, Kaeser B, Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and caucasian volunteers. Antimicrob Agents Chemother. 2008;52:3687–93. DOIPubMedGoogle Scholar